Research Radar — 2026-11-02

Generated 2026-11-02T05:51:48.610486+08:00 approved RSS sources Curated daily research digest; 19/20 primary RSS feeds and 8/8 PubMed-indexed journal feeds available. Indexing may lag publication; coverage is not exhaustive.

Methods & AI

Computational

10 selected
Computational #1 Prioritize the held-out context design and simple baselines; distinguish predicted atlas entries from measured drug responses.

Cross-modal transfer enables zero-shot prediction of drug responses across cell types

bioRxiv Subject Collection: Bioinformatics Published 2026-11-01 Original research preprint; not peer-reviewed DOI: 10.64898/2026.10.27.762107

Authors: Luo, C., Hu, M., Wu, Y., Guo, D., Wang, S., Lyu, Q. R., Liu, X.

perturbation transfer drug response single-cell

Summary: GRAFT uses genetic perturbation responses to predict chemical perturbation responses in unseen cellular contexts. The authors report gains across LINCS and external contexts, with an atlas of 102,128 predicted drug–context combinations.

Why it matters: Genetic and chemical perturbations may share transferable response information beyond baseline expression.

Why for Yiru: Directly relevant to state-dependent perturbation representations and cross-system transfer.

Computational #2 Inspect the API and test one representative tree before adopting it; toolkit availability does not validate every inferred ancestral state.

Pycea: a scverse toolkit for single-cell lineage tracing analysis

bioRxiv Subject Collection: Bioinformatics Published 2026-11-01 Original research preprint; not peer-reviewed DOI: 10.64898/2026.10.30.763227

Authors: Colgan, W. N., Weine, E., Koblan, L. W., Jones, M. G., Weissman, J. S., Yosef, N.

lineage tracing scverse software

Summary: Pycea provides lineage-tree analysis and visualization through TreeData, an AnnData extension. It connects tree statistics, ancestral-state inference and clade analysis to Scanpy/scverse workflows.

Why it matters: A common data structure can reduce friction between lineage information and cell-state analysis.

Why for Yiru: A practical resource for joint lineage, expression and spatial analyses using familiar Python tools.

Computational #3 Check supervision-matched baselines and split independence; treat ranked regulators as hypotheses requiring intervention tests.

FateDriver: Weakly supervised dual-view graph learning for transition-specific prioritization of candidate regulators in cellular reprogramming

bioRxiv Subject Collection: Bioinformatics Published 2026-11-01 Original research preprint; not peer-reviewed DOI: 10.64898/2026.10.27.762150

Authors: Sung, J., Son, K., Cha, H.-J., Kim, W., Lee, H.

reprogramming graph learning positive-unlabeled learning

Summary: FateDriver uses delivered reprogramming factors as sparse labels in a dual-view cell/gene graph model. A positive–unlabeled objective ranks transition-specific regulators, with retrospective recovery assessed in three datasets.

Why it matters: Experimental knowledge can guide regulator prioritization without pretending every unlabeled gene is a true negative.

Why for Yiru: Connects perturbation knowledge, graph representations and context-specific regulatory hypotheses.

Computational #4 Read the label reconstruction and format baseline before pursuing architecture improvements; keep trial context attached to outcomes.

The Quagmire of Immunogenicity-Guided Antibody Design: Labels Limit Progress

bioRxiv Subject Collection: Bioinformatics Published 2026-11-01 Original research preprint; not peer-reviewed DOI: 10.64898/2026.10.27.762175

Authors: Villegas-Morcillo, A., Raman, C., Weber, J. M., Reinders, M. J. T.

benchmark validity label quality immunogenicity

Summary: An antibody immunogenicity benchmark audit finds that antibody format can outperform sequence predictors under existing labels. Reconstructing trial-level measurements reveals large within-molecule variation obscured by a single aggregated label.

Why it matters: A model can learn dataset composition rather than the biological quantity its score appears to represent.

Why for Yiru: A useful warning for perturbation benchmarks and uncertainty models built on heterogeneous experiments.

Computational #5 Inspect spike-in design and validation on endogenous paralogs and isoforms; test whether rescued reads introduce context-specific false assignments.

Transcript quantification using context-aware MAPQ modeling

bioRxiv Subject Collection: Bioinformatics Published 2026-10-31 Original research preprint; not peer-reviewed DOI: 10.64898/2026.10.26.761703

Authors: Hicks, S. C., Parthiban, S.

long-read RNA-seq isoforms measurement model

Summary: CALMeR models expected alignment mapping quality with a zero-one-inflated beta regression conditioned on transcript/read features. The authors report improved spike-in transcript recovery and concentration agreement compared with fixed filtering and quantification baselines.

Why it matters: A context-aware measurement model can retain ambiguous but informative reads instead of discarding them uniformly.

Why for Yiru: Relevant to isoform quantification and explicit modeling of technical observation processes.

Computational #6 Examine assay leakage, acquisition controls and the exact experimental status of each campaign; do not equate a lab-in-the-loop label with prospective wet-lab validation.

Bioactivity foundation model for hit identification and hit-to-lead optimization from sequence data

bioRxiv Subject Collection: Bioinformatics Published 2026-10-31 Original research preprint; not peer-reviewed DOI: 10.64898/2026.10.26.762100

Authors: Koh, H. Y., Koh, H. J. W., Zheng, Y., Naranbhai, V., Schmidt, D. F., Barthelemy, J., Chen, Y.-J., Nguyen, A. T. N., Pan, S., May, L. T., Webb, G. I.

bioactivity distributional learning active learning

Summary: PSICHIC+ predicts binding-affinity distributions from protein sequence and ligand structure, trained on heterogeneous bioactivity records. The authors report virtual-screening and acquisition gains, plus improved hit-to-lead prediction when combined with Boltz-2.

Why it matters: Distributional objectives can retain information about measurement reliability instead of forcing heterogeneous labels into one point target.

Why for Yiru: Relevant to uncertainty-aware experimental prioritization and AI-guided screening.

Computational #7 Read matched-gene and species-native baselines before interpreting zero-shot success as universal biological transfer.

Single-cell foundation models transfer across deep evolutionary distances

bioRxiv Subject Collection: Bioinformatics Published 2026-10-31 Original research preprint; not peer-reviewed DOI: 10.64898/2026.10.28.762457

Authors: Trnovec, L., Katoh-Kurasawa, M., Arey, R. N., Shaulsky, G., Zupan, B.

foundation models cross-species transfer evaluation

Summary: A benchmark tests Geneformer, scGPT and UCE on Dictyostelium and C. elegans atlases without retraining. Protein-sequence-based UCE covers more measured genes and performs most consistently, with some advantages remaining after matched ortholog restrictions.

Why it matters: Gene-vocabulary coverage is a major confounder when comparing cross-species cell representations.

Why for Yiru: Directly relevant to judging foundation-model transfer versus gains from feature availability.

Computational #8 Compare against matched random acquisition and report diversity and cost; require prospective validation before claiming improved laboratory efficiency.

When Does Active Learning Improve ADMET Prediction? A Multi-Endpoint Benchmark

bioRxiv Subject Collection: Bioinformatics Published 2026-10-30 Original research preprint; not peer-reviewed DOI: 10.64898/2026.10.26.761649

Authors: Najdovski, V., Hristova, J., Vodilovska, V., Ivanoska, I.

active learning ADMET uncertainty

Summary: A protocol-matched benchmark compares seven acquisition strategies and two uncertainty approaches across eight ADMET endpoints. Better ensemble prediction did not consistently yield better acquisition; gains depended on endpoint, strategy and chemotype coverage.

Why it matters: Prediction accuracy and experimental selection utility are distinct objectives.

Why for Yiru: Directly relevant to self-driving laboratory design and evaluating whether uncertainty is useful for decisions.

Computational #9 Inspect identifiability assumptions, perturbation validation and comparisons with simpler dynamics before interpreting inferred edges causally.

Mechanistic gene-regulation-based trajectory inference with bowside

bioRxiv Subject Collection: Bioinformatics Published 2026-10-30 Original research preprint; not peer-reviewed DOI: 10.64898/2026.10.26.761800

Authors: Schleicher, J. T., Zago, M., Claassen, M.

trajectory inference gene regulation stochastic dynamics

Summary: bowside is a shallow neural stochastic differentiation model linking trajectory inference with gene regulation. Applications to hematopoiesis and induced-pluripotent-cell reprogramming recover expression trends and known regulatory motifs.

Why it matters: Mechanistic structure offers an alternative to learning trajectories and regulatory networks as unrelated stages.

Why for Yiru: Relevant to interpretable dynamical models and the connection between state changes and regulatory programs.

Computational #10 Reproduce hardware-matched speed and biological-conservation checks; numerical correlation and one atlas do not guarantee universal integration quality.

flashscenic: Accelerated GRN Analysis with RegDiffusion for Large-Scale Single-Cell Data

bioRxiv Subject Collection: Bioinformatics Published 2026-10-30 Original research preprint; not peer-reviewed DOI: 10.64898/2026.10.26.761795

Authors: Zhu, H., Cardenal-Antolin, G., Jin, X., Gootenberg, J. S., Abudayyeh, O. O., Slonim, D. K.

GRN GPU acceleration batch integration

Summary: flashscenic accelerates SCENIC-style regulon analysis with GPU tensor operations and reports 12–27-fold downstream speedups. Repeated runs support consensus analysis; an AML atlas evaluates regulon activities as integration features.

Why it matters: Faster repeated analysis can make network stability checks practical rather than optional.

Why for Yiru: Relevant to scalable, interpretable cell-state representations and batch-effect evaluation.

Biomedical discoveries

Biomedicine

1 selected
Biomedicine #1 Inspect donor-level replication and disease–study confounding; recurring signatures nominate hypotheses rather than proving a common therapeutic target.

Development of a multi-organ single-cell atlas of systemic sclerosis reveals shared and tissue-specific pathogenic pathways.

bioRxiv Subject Collection: Immunology Published 2026-10-31 Original research preprint; not peer-reviewed DOI: 10.64898/2026.10.26.761913

Authors: Iperi, C., Geiss, C., Lugar, M., Stauffer, P., Vlachogiannis, N., Hofman, A., Khmelevskaya, A., Sfikakis, P. P., Hoffmann-Vold, A.-M., Micheroli, R., Seiler, C., Distler, O., Ospelt, C., Elhai, M.

single-cell atlas systemic sclerosis tissue context

Summary: A systemic-sclerosis atlas integrates six studies across skin, lung, synovium and blood, totaling 401,902 cells from 90 people. Pseudobulk analyses find tissue-dependent disease programs alongside recurring fibrotic and interferon signatures.

Why it matters: Shared cell lineages can exhibit substantially different disease-associated responses in different organs.

Why for Yiru: Useful biological context for distinguishing shared programs from tissue-specific state effects.

Methodology Review: Multilevel Monte Carlo: spend precision where the correction needs it

English · About 10 minutes

The estimator is checked against the corrected author survey; application readings are abstract-level. The Gaussian example and its costs are illustrative, independently calculated, and not experimental benchmarks. Numerical error is distinct from model and biological uncertainty.

The intuition

Suppose a stochastic simulator can run cheaply at a coarse resolution or expensively at a fine resolution. You want the average of one output, not a perfect picture of every trajectory. Paying for thousands of fine runs may be wasteful if most variability is already visible in coarse runs. Multilevel Monte Carlo estimates a cheap baseline and then estimates the correction that higher resolution adds. Its organizing question is not which simulation looks best, but which difference still needs expensive sampling. [R1]

This follows naturally from variance reduction, but adds a different computational design problem: how to couple neighboring resolutions, choose the finest resolution, and divide samples between levels. It is not simply averaging predictions from unrelated models. Keep the output definition fixed across the hierarchy. If one level predicts total molecules and another predicts a normalized score, subtraction has no agreed scientific meaning until a common observable is specified. The hierarchy must serve one target, not conceal a change in the question.

A small worked example

Consider an invented two-level simulator with outputs \(P_0=10+2Z\) and \(P_1=10.4+2Z+0.2W\), where \(Z\) and \(W\) are independent standard normal random variables, each with mean zero and variance one. Subscripts zero and one label coarse and fine resolution. For a paired correction, use the same draw of \(Z\) in both outputs. Then \(D_1=P_1-P_0=0.4+0.2W\). The coarse variance is four, the correction variance is 0.04, and the fine-output variance is 4.04. These are constructed numbers, not measured biological performance.

Assume one coarse sample costs one unit and a paired correction costs 25 units, including both computations. We seek sampling variance no larger than 0.01 for the estimated fine mean. Take 600 independent coarse samples and 12 independent paired corrections, with independent random streams between the two groups. The estimator is the coarse sample mean plus the correction sample mean. Its expectation is 10.4, and its variance is \(4/600+0.04/12=0.01\). Total cost is \(600+25\times12=900\) units.

For comparison, suppose a standalone fine run also costs 25 units. Ordinary Monte Carlo needs 404 independent fine draws because \(4.04/404=0.01\), costing 10,100 units. Under these deliberately favorable assumptions, the cost ratio is about 11.2. This is an arithmetic demonstration, not a promised acceleration factor. We chose a cheap component that explains nearly all variation and a correction that is easy to estimate. Real pilot runs must establish whether either property holds.

Now break the pairing: draw unrelated coarse and fine outputs inside each difference. Its variance becomes \(4.04+4=8.04\) rather than 0.04. The expectation still telescopes, but the useful cancellation is gone. This separates correctness from efficiency: an estimator can aim at the right mean while spending far too much effort. Also notice that twelve fine corrections do not mean twelve independent biological replicates. All samples here come from an assumed simulator, so they quantify numerical sampling error under that model.

The necessary mathematics

Let \(P\) denote the ideal output and \(P_\ell\) its approximation at resolution level \(\ell\), with finest level \(L\). Define \(D_0=P_0\) and \(D_\ell=P_\ell-P_{\ell-1}\) for positive levels. Linearity gives the telescoping identity

\[\mathbb{E}[P_L]=\sum_{\ell=0}^{L}\mathbb{E}[D_\ell].\]

Expectation is denoted by \(\mathbb{E}\). Estimate each term by an independent sample average; couple the two outputs within every positive-level difference. [R1]

Write \(N_\ell\) for the number of independent samples at level \(\ell\), \(V_\ell=\operatorname{Var}(D_\ell)\) for correction variance, and \(C_\ell\) for expected cost per correction. With independent level estimators, total sampling variance is \(\sum_{\ell=0}^{L}V_\ell/N_\ell\) and expected cost is \(\sum_{\ell=0}^{L}N_\ell C_\ell\). Minimizing cost for a fixed variance budget yields \(N_\ell\propto\sqrt{V_\ell/C_\ell}\) before integer rounding. In our toy problem this gives a coarse-to-fine sample ratio of fifty, exactly the ratio of 600 to twelve. [R1]

The estimator targets \(\mathbb{E}[P_L]\), not automatically \(\mathbb{E}[P]\). Let \(Y\) be the multilevel estimate. Its mean-squared error for the ideal mean is

\[\mathbb{E}[(Y-\mathbb{E}[P])^2]=\operatorname{Var}(Y)+(\mathbb{E}[P_L]-\mathbb{E}[P])^2.\]

The second term is squared discretization bias. More samples reduce the first term; finer resolution addresses the second. This distinction underlies the original SDE complexity analysis, whose rate improvement requires specific regularity and discretization conditions. [R1] [R2]

Assumptions and failure modes

The central practical test is whether correction variance falls fast enough to compensate for rising cost. Measure both quantities before committing the budget. Anderson, Higham and Sun analyze correction variance directly for scaled jump systems and show why a convenient second-moment bound can be unnecessarily loose. Their result is a reminder that the relevant quantity is variation in the difference, not merely accuracy of each separate path. A hierarchy with excellent-looking trajectories can still have poor coupling. [R4]

Pilot variance estimates can themselves be unstable, especially if occasional rare trajectories dominate the output. Treat a tiny estimated correction variance from a few draws as provisional. Record random-stream construction, sample counts, runtimes, and the observable before comparing algorithms. For the toy example, one useful stress test is to replace the correction with rare, large deviations and see whether a short pilot misses them. This is a proposed diagnostic exercise, not an error guarantee or a reproduction of the cited papers.

A numerical confidence interval does not cover uncertainty about reaction rates, missing mechanisms, or whether the simulator describes the experiment. Those uncertainties require an explicit outer model or sensitivity analysis. Nor does an exact telescoping identity ensure that approximate levels preserve valid states: a discretization can generate impossible values unless its own safeguards are respected. Use an appropriate simulation method rather than treating multilevel sampling as a repair for a scientifically invalid simulator.

Verified applications

Giles’s original path-simulation paper establishes a conditional complexity improvement for SDE expectations using Euler discretization and Lipschitz observables, with numerical examples. Anderson and Higham extend the construction to continuous-time Markov chains motivated by biochemical kinetics. Their coupling and exact-process correction can produce an unbiased estimator for the exact-chain expectation. That is an established biochemical simulation application, not evidence that any learned virtual-cell model can be corrected this way. Application claims here are bounded to the inspected primary abstracts and institutional publication records; no numerical benchmarks were independently reproduced. [R2] [R3]

Possible transfers — speculative

A possible omics-facing use would be estimating the expected output of a mechanistic stochastic model at several numerical resolutions, after defining one biologically meaningful scalar observable. First test whether coarse and fine paths can share randomness without changing their required marginal distributions. Then compare correction variance, bias estimates and wall-clock cost against ordinary fine-resolution simulation. This is a speculative workflow proposal. A collection of independently trained neural networks is not already such a hierarchy, and their agreement does not establish convergence to biological truth.

Start with the constructed two-level example and verify its expectation, variance and cost by hand. Then remove shared randomness and explain why correctness survives while efficiency disappears. Only after that should you replace the toy model with a simulator. The decision to proceed should rest on observed correction variance and cost, a justified finest-level target, and an explicit bias check. The useful habit is to ask what must be simulated accurately and what can be estimated cheaply, while refusing to confuse numerical precision with experimental validity.

Reading list

  • [R1] Primary reading: Multilevel Monte Carlo methods. Michael B. Giles (2015). Start with sections 1–3 of the corrected author copy. The author explicitly notes corrections; use the publisher’s 2015 date rather than the PDF’s later draft header. The similarly titled 2013 conference survey is tracked conservatively as related work, not asserted identical.

  • [R2] Related reading: Multilevel Monte Carlo Path Simulation. Michael B. Giles (2008). Read the original SDE application for what its smoothness and discretization assumptions buy. The reported complexity result is conditional, not a universal acceleration claim.

  • [R3] Related reading: Multilevel Monte Carlo for continuous time Markov chains, with applications in biochemical kinetics. David F. Anderson and Desmond J. Higham (2012). Read the established biochemical simulation application, especially how coarse and fine jump processes are coupled and how an exact correction changes the estimator target.

  • [R4] Related reading: Complexity of Multilevel Monte Carlo Tau-Leaping. David F. Anderson, Desmond J. Higham and Yu Sun (2014). Read for why correction variance and system scaling need direct analysis, rather than importing a diffusion bound into a jump process.

Page Last Updated: